SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Feldmeier JJ. Hyperbaric oxygen for delayed radiation injuries. Undersea Hyperb Med. 2004; 31: 133-145.
  • 2
    Hyperbaric Oxygen Therapy Committee. Hyperbaric oxygen 2008: indications and results. The Hyperbaric Oxygen Therapy Committee Report. In: Gesell L, ed. Durham, NC: Undersea and Hyperbaric Medical Society; 2008.
  • 3
    Denham JW, Hauer-Jensen M. The radiotherapeutic injury—a complex “wound.” Radiother Oncol. 2002; 63: 129-145.
  • 4
    Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004; 73: 199-131.
  • 5
    Bentzen SM, Parliament M, Deasy JO, et al. Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects. Int J Radiat Oncol Biol Phys. 2010; 76( 3 suppl): S145-S150.
  • 6
    Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983; 41: 283-288.
  • 7
    Beehner MR, Marx RE. Hyperbaric oxygen induced angiogenesis and fibroplasias in human irradiated tissues. In: Proceedings of the 65th Meeting of the American Association of Oral and Maxillofacial Surgeons. Rosemont, IL: American Association of Oral and Maxillofacial Surgeons; 1983: 78-79.
  • 8
    Milovanova TN, Bohpale BM, Sorokina EM, et al. Hyperbaric oxygen induces vasulogenic stem cell growth and differentiation. J Appl Phys. 2009; 106: 711-728.
  • 9
    Feldmeier JJ, Jelen I, Davolt DA, Valente PT, Meltz ML, Alecu R. Hyperbaric oxygen as a prophylaxis for radiation induced delayed enteropathy. Radiother Oncol. 1995; 35: 138-144.
  • 10
    Feldmeier JJ, Davolt DA, Court WS, Onoda JM, Alecu R. Histologic morphometry confirms a prophylactic effect for hyperbaric oxygen in the prevention of delayed radiation enteropathy. Undersea Hyperb Med. 1998; 25: 93-97.
  • 11
    Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, Buerk DG. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol. 2006; 290: H1378-H1386.
  • 12
    Bui QC, Lieber M, Withers HR, et al. The efficacy of hyperbaric oxygen therapy in the treatment of radiation-induced side effects. Int J Radiat Oncol Biol Phys. 2004; 60: 871-878.
  • 13
    Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc. 1985; 111: 49-54.
  • 14
    Pritchard J, Anand P, Broome J, et al. Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy. Radiother Oncol. 2001; 58: 279-286.
  • 15
    Clarke RE, Tenorio LM, Hussey JR, et al. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008; 72: 134-143.
  • 16
    Gothard L, Haviland J, Bryson P, et al. Randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema after radiotherapy for cancer. Radiother Oncol. 2010; 97: 101-107.
  • 17
    Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med. 2002; 29: 4-30.
  • 18
    Bennett MH, Feldmeier J, Hampson N, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2005;( 3): CD005005.
  • 19
    Centers for Medicare and Medicaid Services (CMS). Medicare Coverage Database: “National Coverage Decision for Hyperbaric Oxygen Therapy.” Manual section 20.29, revision 77 (effective date September 12, 2007). Bethesda, MD: Centers for Medicare and Medicaid Services; 2010.
  • 20
    Hampson NB, Corman JM. Rate of delivery of hyperbaric oxygen treatments does not affect response in soft tissue radionecrosis. Undersea Hyperb Med. 2007; 34: 329-334.
  • 21
    Chong KT, Hampson NB, Corman JM. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. J Urol. 2005; 65: 649-653.
  • 22
    Corman JM, McClure RD, Pritchett TR, Kozlowski P, Hampson NB. Treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen. J Urol. 2003; 169: 2200-2202.
  • 23
    Dall'Era MA, Hampson NB, Hsi RA, Madsen B, Corman JM. Hyperbaric oxygen therapy for radiation-induced proctopathy in men with prostate cancer. J Urol. 2006; 176: 87-90.
  • 24
    Marshall GT, Thirlby RC, Bredfeldt JE, Hampson NB. Treatment of gastrointestinal radiation injury with hyperbaric oxygen. Undersea Hyperb Med. 2007; 34: 35-42.
  • 25
    Chandler JR. Radiation fibrosis and necrosis of the larynx. Ann Oto Rhinol Laryngol. 1979; 88: 509-514.
  • 26
    Dickersin K. The existence of publication bias and risk factors for its occurrence. JAMA. 1990; 263: 1385-1359.
  • 27
    Albrecht J, Meves A, Bigby M. A survey of case reports and case series of therapeutic interventions in the Archives of Dermatology. Int J Dermatol. 2009; 48: 592-597.